Early trials demonstrate that the compound – a dual stimulator of incretin and a related hormone receptors – presents a substantial improvement in weight management programs . In contrast to existing therapies, the peptide seems to affect food intake and energy expenditure by means of distinct mechanisms . While more examination is essential,